VentafriddaV, RipamontiC, De ConnoF, TamburiniM, CassilethBR. Symptom prevalence and control during cancer patients’ last days of life. J Palliat Care1990; 6 (4):7–11.
2.
ChernyNI, PortenoyRK. Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care1994; 10 (2):31–39.
3.
GreeneWR, DavisWH. Titrated intravenous barbiturates in the control of symptoms in patients with terminal cancer. South Med J1991; 84 (3):332–337.
4.
McIverB, WalshD, NelsonK.The use of chlorpromazine for symptom control in dying cancer patients. J Pain Sympt Manag1994; 9 (5):341–345.
5.
CavanaughTA. The ethics of death-hastening or death-causing palliative analgesic administration to the terminally ill. J Pain Sympt Manag1996; 12 (4):248–254.
6.
Association for Palliative Medicine: Report of the Select Committee on Medical Ethics. Southampton: Association of Palliative Care, 1993.
7.
TwycrossRG. Euthanasia: going Dutch. J Roy Soc Med1996; 89 (2):61–63.
8.
World Health Organization: Cancer Pain Relief, 2nd edition. Geneva: World Health Organization, 1996.
9.
TwycrossRG. Clinical experience with diamorphine in advanced malignant disease. Int J Clin Pharmacol Ther Toxicol1974; 7 (3):184–198.
10.
BresciaFJ, PortenoyRK, RyanM, DrasnoffL, GrayG.Pain, opioid use and survival in hospitalized patients with advanced cancer. J Clin Oncol1992; 10 (1):149–155.
11.
HendinH, KlermanG.Physician-assisted suicide: the dangers of legalization. Am J Psych1993; 150 (1):143–145.
12.
FoleyKM. The relationship of pain and symptom management to patient requests for physician-assisted suicide. J Pain Sympt Manag1991; 6: 289–297.
